{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-019839","form_type":"8-K","ticker":"CELU","cik":"0001752828","company_name":"Celularity Inc","filed_at":"2025-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.340327+00:00","generated_at":"2026-05-17T01:57:54.798996+00:00","sec_items":["1.01","3.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Celularity raises $2M initial tranche in $6.67M private placement of Series A Preferred and warrants","bullets":["Series A Preferred shares sold at 90% of stated value; $2M initial tranche closed Oct 24, 2025.","Up to three tranches totaling $6.67M stated value; warrants exercisable at $3.00/share for 25% of purchase price.","Conversion price lower of 110% of prior close or 95% of 7-day VWAP, floor $1.60; 5% dividend (18% on trigger event).","Proceeds used for working capital; investor capped at 4.99% beneficial ownership unless waived.","Shares issued exempt under Section 4(a)(2) and Regulation D; resale registration required within 30 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-019839","json":"https://secwatch.observer/filing/0001493152-25-019839.json","markdown":"https://secwatch.observer/filing/0001493152-25-019839.md","text":"https://secwatch.observer/filing/0001493152-25-019839.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225019839/0001493152-25-019839-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225019839/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:57:54.798996+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5e09a767a2e297caa02e0eee8cb642ec73f27849","claim":"Celularity Inc issued preferred stock to an institutional investor for 90% of the stated value.","evidence_excerpt":"with the Series A Preferred Stock, the “Securities”). Under the Purchase Agreement, the Series A Preferred Stock will be issued and sold at a purchase price equal to 90% of the stated value, with each Preferred Share having a stated value of $1.111111 per share, and the Warrants will be issued for no additional consideration. Each Warrant will","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225019839/0001493152-25-019839-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"preferred stock"},{"label":"Purchaser","value":"an institutional investor"},{"label":"Consideration","value":"90% of the stated value"}],"fact_type":"equity_issuance"},{"claim_id":"f64063b65b4f51b7a0bf2a011b8eaa592bca6a8d","claim":"Celularity Inc: Filed Certificate of Designation for Series A Convertible Preferred Stock, establishing rights and preferences for 6,000,000 shares of Series A Preferred Stock (effective 2025-10-24).","evidence_excerpt":"On October 24, 2025, the Company filed a Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, designating 6,000,000 shares of Series A Preferred Stock, out of the Company’s authorized preferred stock.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315225019839/0001493152-25-019839-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-10-24"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}